Biology of chronic graft-versus-host disease: implications for a future therapeutic approach.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The Keio Journal of Medicine

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2302/KJM.57.177PMID 19110529PMCID PMC2722785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease.

  2007cited by this paper
• FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation

  2007cited by this paper
• Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.

  2007cited by this paper
• TGFbeta signalling in control of T-cell-mediated self-reactivity.

  2007cited by this paper
• Regulatory dendritic cells protect against cutaneous chronic graft-versus-host disease mediated through CD4+CD25+Foxp3+ regulatory T cells.

  2007cited by this paper
• High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease

  2007cited by this paper
• TGFβ signalling in control of T-cell-mediated self-reactivity

  2007cited by this paper
• Absence of cutaneous TNFalpha-producing CD4+ T cells and TNFalpha may allow for fibrosis rather than epithelial cytotoxicity in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.

  2007cited by this paper
• Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease.

  2007cited by this paper
• Prediction of Graft-Versus-Host Disease in Humans by Donor Gene-Expression Profiling

  2007cited by this paper
• Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.

  2007cited by this paper
• Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.

  2007cited by this paper
• CD4+ T Cells Generated De Novo from Donor Hemopoietic Stem Cells Mediate the Evolution from Acute to Chronic Graft-versus-Host Disease1

  2007cited by this paper
• Rituximab for steroid-refractory chronic graft-versus-host disease.

  2006cited by this paper
• Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

  2006cited by this paper
• Costimulatory molecule-targeted immunotherapy of cutaneous graft-versus-host disease.

  2006cited by this paper
• Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations.

  2006cited by this paper
• Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

  2006cited by this paper
• Alloreactive Memory T Cells Are Responsible for the Persistence of Graft-versus-Host Disease1

  2005cited by this paper
• Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs.-host disease.

  2005cited by this paper
• National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

  2005cited by this paper
• TGF-β in allogeneic stem cell transplantation: friend or foe?

  2005cited by this paper
• Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans

  2005cited by this paper
• Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.

  2005cited by this paper
• TGF-beta in allogeneic stem cell transplantation: friend or foe?

  2005cited by this paper
• Emergent autoimmunity in graft-versus-host disease.

  2005cited by this paper
• Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.

  2005cited by this paper
• Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease.

  2004cited by this paper
• Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.

  2004cited by this paper
• Fibrotic disease and the TH1/TH2 paradigm

  2004cited by this paper
• Target Antigens Determine Graft-versus-Host Disease Phenotype

  2004cited by this paper
• Chronic graft versus host disease

  2004cited by this paper
• Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.

  2004cited by this paper
• Association of Foxp3 regulatory gene expression with graft-versus-host disease.

  2004cited by this paper
• Fibrotic disease and the T(H)1/T(H)2 paradigm.

  2004cited by this paper
• A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.

  2004cited by this paper
• TGF‐β Induces Foxp3 + T‐Regulatory Cells from CD4 + CD25 − Precursors

  2004cited by this paper
• Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model.

  2003cited by this paper
• Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.

  2003cited by this paper
• Impaired thymic negative selection causes autoimmune graft-versus-host disease.

  2003cited by this paper
• Chronic graft-versus-host disease.

  2003cited by this paper
• Memory CD4+ T cells do not induce graft-versus-host disease.

  2003cited by this paper
• Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma: Cutaneous Cytokines, Chemokines, and Immune Cell Activation1

  2002cited by this paper
• MHC-II-Independent CD4+ T Cells Induce Colitis in Immunodeficient RAG−/− Hosts1

  2001cited by this paper
• Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets.

  2000cited by this paper
• Abrogation of negative selection by GVHR induced by minor histocompatibility antigens or H-2D antigen alone.

  2000cited by this paper
• Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease.

  1999cited by this paper
• Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.

  1999cited by this paper
• Protection from radiation-induced colitis requires MHC class II antigen expression by cells of hemopoietic origin.

  1999cited by this paper
• Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.

  1998cited by this paper
• Polymorphisms in the tumor necrosis factor alpha (TNF-alpha) gene correlate with murine resistance to development of toxoplasmic encephalitis and with levels of TNF-alpha mRNA in infected brain tissue

  1992cited by this paper
• AUTOIMMUNITY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION A STUDY OF 53 LONG‐TERM‐SURVIVING PATIENTS

  1988cited by this paper
• Complete sequential regeneration of graft-vs.-host-induced severely dysplastic thymuses. Implications for the pathogenesis of chronic graft-vs.-host disease.

  1988cited by this paper
• Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice

  1987cited by this paper
• Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.

  1986cited by this paper
• Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis.

  1985cited by this paper
• Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems.

  1983cited by this paper
• Cell-mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-vs-host disease.

  1980cited by this paper
• Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man.

  1978cited by this paper

• Cytomegalovirus infection is associated with thymic dysfunction and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation.

  2024cites this paper
• Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.

  2022cites this paper
• Evaluating differential expression of fibrosis-related genes and their correlation with blood vessel density in chronic cutaneous graft-versus-host disease.

  2022cites this paper
• Potential of TCR sequencing in graft-versus-host disease

  2022cites this paper
• Steroid-refractory chronic graft-versus-host disease: treatment options and patient management

  2021influential citation
• Oral manifestations of graft-versus-host disease in patients submitted to allogeneic hematopoietic stem cell transplantation: the experience of a Brazilian Cancer Center

  2021cites this paper
• Should we use extracorporeal photopheresis more often? Evidence from graft-versus-host disease patients monitored with Treg as a biomarker

  2020cites this paper
• Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease

  2019cites this paper
• Restoring T Cell Homeostasis After Allogeneic Stem Cell Transplantation; Principal Limitations and Future Challenges

  2018cites this paper
• Bortezomib is safe in and stabilizes pulmonary function in patients with allo-HSCT-associated pulmonary CGVHD

  2018cites this paper
• Reconstitution of Th17, Tc17 and Treg cells after paediatric haematopoietic stem cell transplantation: Impact of interleukin-7.

  2018cites this paper
• Chronic oral Graft-versus-Host Disease: clinical risk factors and biochemical markers of disease activity

  2017cites this paper
• Association of Day-100 Oral GVHD with subsequent Chronic GVHD Diagnosed by NIH 2005 Consensus Criteria and Treated with Systemic Immunosuppression

  2017cites this paper
• Extracorporeal photopheresis did not prevent the development of an autoimmune disease: myasthenia gravis

  2016cites this paper
• Plasma Kinetics of Th1, Th2 and Th17 Cytokines in Polymyositis Related to Chronic Graft-versus-Host Disease.

  2016cites this paper
• Фотоферез при трансплантации почек

  2016cites this paper
• The antibacterial properties of oral mucosa lamina propria-progenitor cells.

  2016cites this paper
• Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.

  2015cites this paper
• State-of-the-art acute and chronic GVHD treatment

  2015cites this paper
• Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.

  2015cites this paper
• Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab

  2014cites this paper
• Breakdown of thymic tolerance - an etiologic link between acute and chronic graft-versus-host disease

  2014cites this paper
• Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.

  2014cites this paper
• Updating ECP action mechanisms.

  2014cites this paper
• Células troncales mesenquimales: potencial de terapia celular en trasplante de células troncales hematopoyéticas

  2014cites this paper
• Cutaneous Chronic Graft‐Versus‐Host Disease

  2013cites this paper
• More than skin deep? Emerging therapies for chronic cutaneous GVHD

  2013cites this paper
• Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant

  2013cites this paper
• Epithelial cytoprotection sustains ectopic expression of tissue-restricted antigens in the thymus during murine acute GVHD.

  2013cites this paper
• Association between genetic variants in adhesion molecules and outcomes after hematopoietic cell transplants

  2013cites this paper
• Roles of transforming growth factor-β in graft-versus-host and graft-versus-tumor effects.

  2012cites this paper
• Eosinophils in Human Disease

  2012cites this paper
• Bone marrow transplantation: graft versus host disease and oral changes

  2012cites this paper
• Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

  2011cites this paper
• Myofibroblasts and polyploid cells in the conjunctival surface after allogeneic hematopoietic stem cell transplantation

  2011cites this paper
• Health consensus criteria and for chronic graft-versus-host disease according to National Comparative analysis of risk factors for acute graft-versus-host disease

  2011cites this paper
• Tirosin Kinase Inhibitors in Chronic Graft versus Host Disease: From Bench to Bedside

  2011cites this paper
• Graft-vs-host disease following allogeneic hematopoietic cell transplantation.

  2011cites this paper
• Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity

  2011cites this paper
• Thymic T-cell development in allogeneic stem cell transplantation.

  2011cites this paper
• The kinetics of mRNA transforming growth factor beta1 expression and its serum concentration in graft-versus-host disease after allogeneic hemopoietic stem cell transplantation for myeloid leukemias

  2011cites this paper
• Investigation of the effect of donor platelet endothelial cell adhesion molecule 1 polymorphism on the graft-vs.-host disease occurrence in Tunisian recipients of hematopoietic stem cells.

  2011cites this paper
• Study of the Incidence of Muco-cutaneous Graft Versus Host Disease among patients undergoing Allogeneic Hematopoietic Stem Cell Transplantation in an Indian setting

  2011cites this paper
• Extracorporeal photochemotherapy induces arginase 1 in patients with graft versus host disease.

  2011cites this paper
• Graft-versus-Host-Erkrankung der Haut

  2011cites this paper
• Slashing the picture of Dorian Gray.

  2011cites this paper
• Polymorphisms in the Base Excision Repair Pathway and Graft-versus-Host Disease

  2010cites this paper
• The chemokine system: a possible therapeutic target in acute graft versus host disease.

  2010cites this paper
• Immune Processes and Pathogenic Fibrosis in Ocular Chronic Graft-Versus-Host Disease and Clinical Manifestations after Allogeneic Hematopoietic Stem Cell Transplantation

  2010cites this paper
• Modulation des réactions alloimmunitaires par les cytokines maîtresses IFN-γ et TGF-β

  2010cites this paper
• Étude des mécanismes d'action de la PhotoChimiothérapie Extra-corporelle chez l'Homme

  2010cites this paper
• Skin: Cutaneous Toxicities

  2010cites this paper
• The role of the thymus in allogeneic hematopoietic stem cell transplantation.

  2010cites this paper
• Clinical update on graft-versus-host disease in children.

  2010cites this paper
• Photochemotherapy Induces a Faster Apoptosis of Alloreactive Activated T Cells Than of Nonalloreactive Resting T Cells in Graft Versus Host Disease

  2010cites this paper
• Pleiotropic effects of transforming growth factor-β in hematopoietic stem-cell transplantation.

  2010cites this paper
• Genital manifestation of graft-vs.-host disease: a series of case reports.

  2010cites this paper
• Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.

  2010cites this paper
• The role of photopheresis in the treatment of graft-versus-host disease.

  2010cites this paper
• Dermatologic manifestations of hematopoietic stem cell transplantation: understanding and management

  2009cites this paper